{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T14:43:15Z","timestamp":1761662595838},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1007\/s00467-008-0781-6","type":"journal-article","created":{"date-parts":[[2008,3,19]],"date-time":"2008-03-19T10:58:55Z","timestamp":1205924335000},"page":"1355-1361","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Rituximab treatment of collapsing C1q glomerulopathy: clinical and histopathological evolution"],"prefix":"10.1007","volume":"23","author":[{"given":"Martin","family":"Bitzan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jodie D.","family":"Ouahed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Preetha","family":"Krishnamoorthy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chantal","family":"Bernard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,8,1]]},"reference":[{"key":"781_CR1","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1038\/ki.1996.493","volume":"50","author":"A Valeri","year":"1996","unstructured":"Valeri A, Barisoni L, Appel GB, Seigle R, D'Agati V (1996) Idiopathic collapsing focal segmental glomerulosclerosis: a clinicopathologic study. Kidney Int 50:1734\u20131746","journal-title":"Kidney Int"},{"key":"781_CR2","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1038\/sj.ki.5000160","volume":"69","author":"DB Thomas","year":"2006","unstructured":"Thomas DB, Franceschini N, Hogan SL, Ten Holder S, Jennette CE, Falk RJ, Jennette JC (2006) Clinical and pathologic characteristics of focal segmental glomerulosclerosis pathologic variants. Kidney Int 69:920\u2013926","journal-title":"Kidney Int"},{"key":"781_CR3","doi-asserted-by":"publisher","first-page":"2854","DOI":"10.1681\/ASN.2006030225","volume":"17","author":"M Albaqumi","year":"2006","unstructured":"Albaqumi M, Soos TJ, Barisoni L, Nelson PJ (2006) Collapsing glomerulopathy. J Am Soc Nephrol 17:2854\u20132863","journal-title":"J Am Soc Nephrol"},{"key":"781_CR4","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S0272-6386(85)80150-5","volume":"6","author":"JC Jennette","year":"1985","unstructured":"Jennette JC, Hipp CG (1985) C1q nephropathy: a distinct pathologic entity usually causing nephrotic syndrome. Am J Kidney Dis 6:103\u2013110","journal-title":"Am J Kidney Dis"},{"key":"781_CR5","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S0272-6386(12)80114-4","volume":"18","author":"SS Iskandar","year":"1991","unstructured":"Iskandar SS, Browning MC, Lorentz WB (1991) C1q nephropathy: a pediatric clinicopathologic study. Am J Kidney Dis 18:459\u2013465","journal-title":"Am J Kidney Dis"},{"key":"781_CR6","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1046\/j.1523-1755.2003.00218.x","volume":"64","author":"GS Markowitz","year":"2003","unstructured":"Markowitz GS, Schwimmer JA, Stokes MB, Nasr S, Seigle RL, Valeri AM, D'Agati VD (2003) C1q nephropathy: a variant of focal segmental glomerulosclerosis. Kidney Int 64:1232\u20131240","journal-title":"Kidney Int"},{"key":"781_CR7","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1007\/s00467-004-1810-8","volume":"20","author":"KK Lau","year":"2005","unstructured":"Lau KK, Gaber LW, Delos Santos NM, Wyatt RJ (2005) C1q nephropathy: features at presentation and outcome. Pediatr Nephrol 20:744\u2013749","journal-title":"Pediatr Nephrol"},{"key":"781_CR8","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1007\/s00467-005-2040-4","volume":"20","author":"T Kersnik Levart","year":"2005","unstructured":"Kersnik Levart T, Kenda RB, Avgustin Cavic M, Ferluga D, Hvala A, Vizjak A (2005) C1Q nephropathy in children. Pediatr Nephrol 20:1756\u20131761","journal-title":"Pediatr Nephrol"},{"key":"781_CR9","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1053\/j.ajkd.2005.11.013","volume":"47","author":"Y Fukuma","year":"2006","unstructured":"Fukuma Y, Hisano S, Segawa Y, Niimi K, Tsuru N, Kaku Y, Hatae K, Kiyoshi Y, Mitsudome A, Iwasaki H (2006) Clinicopathologic correlation of C1q nephropathy in children. Am J Kidney Dis 47:412\u2013418","journal-title":"Am J Kidney Dis"},{"key":"781_CR10","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1111\/j.1600-6143.2006.01288.x","volume":"6","author":"MD Pescovitz","year":"2006","unstructured":"Pescovitz MD (2006) Rituximab, an anti-CD20 monoclonal antibody: history and mechanism of action. Am J Transplant 6:859\u2013866","journal-title":"Am J Transplant"},{"key":"781_CR11","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1097\/01.ASN.0000071511.35221.B3","volume":"14","author":"P Ruggenenti","year":"2003","unstructured":"Ruggenenti P, Chiurchiu C, Brusegan V, Abbate M, Perna A, Filippi C, Remuzzi G (2003) Rituximab in idiopathic membranous nephropathy: a one-year prospective study. J Am Soc Nephrol 14:1851\u20131857","journal-title":"J Am Soc Nephrol"},{"key":"781_CR12","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1002\/art.20858","volume":"52","author":"PP Sfikakis","year":"2005","unstructured":"Sfikakis PP, Boletis JN, Lionaki S, Vigklis V, Fragiadaki KG, Iniotaki A, Moutsopoulos HM (2005) Remission of proliferative lupus nephritis following B cell depletion therapy is preceded by down-regulation of the T cell costimulatory molecule CD40 ligand: an open-label trial. Arthritis Rheum 52:501\u2013513","journal-title":"Arthritis Rheum"},{"key":"781_CR13","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/ncpneph0133","volume":"2","author":"AD Salama","year":"2006","unstructured":"Salama AD, Pusey CD (2006) Drug insight: rituximab in renal disease and transplantation. Nat Clin Pract Nephrol 2:221\u2013230","journal-title":"Nat Clin Pract Nephrol"},{"key":"781_CR14","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s00296-007-0471-x","volume":"28","author":"DG Arkfeld","year":"2008","unstructured":"Arkfeld DG (2008) The potential utility of B cell-directed biologic therapy in autoimmune diseases. Rheumatol Int 28:205\u2013215","journal-title":"Rheumatol Int"},{"key":"781_CR15","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1007\/s00467-004-1434-z","volume":"19","author":"K Benz","year":"2004","unstructured":"Benz K, Dotsch J, Rascher W, Stachel D (2004) Change of the course of steroid-dependent nephrotic syndrome after rituximab therapy. Pediatr Nephrol 19:794\u2013797","journal-title":"Pediatr Nephrol"},{"key":"781_CR16","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1007\/s00467-006-0228-x","volume":"21","author":"RD Gilbert","year":"2006","unstructured":"Gilbert RD, Hulse E, Rigden S (2006) Rituximab therapy for steroid-dependent minimal change nephrotic syndrome. Pediatr Nephrol 21:1698\u20131700","journal-title":"Pediatr Nephrol"},{"key":"781_CR17","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1053\/j.ajkd.2006.10.015","volume":"49","author":"H Francois","year":"2007","unstructured":"Francois H, Daugas E, Bensman A, Ronco P (2007) Unexpected efficacy of rituximab in multirelapsing minimal change nephrotic syndrome in the adult: first case report and pathophysiological considerations. Am J Kidney Dis 49:158\u2013161","journal-title":"Am J Kidney Dis"},{"key":"781_CR18","doi-asserted-by":"publisher","first-page":"2751","DOI":"10.1056\/NEJMc063706","volume":"356","author":"A Bagga","year":"2007","unstructured":"Bagga A, Sinha A, Moudgil A (2007) Rituximab in patients with the steroid-resistant nephrotic syndrome. N Engl J Med 356:2751\u20132752","journal-title":"N Engl J Med"},{"key":"781_CR19","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00467-007-0596-x","volume":"23","author":"J Dotsch","year":"2008","unstructured":"Dotsch J, Muller-Wiefel DE, Kemper MJ (2008) Rituximab: is replacement of cyclophosphamide and calcineurin inhibitors in steroid-dependent nephrotic syndrome possible? Pediatr Nephrol 23:3\u20137","journal-title":"Pediatr Nephrol"},{"key":"781_CR20","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1002\/eji.200424904","volume":"34","author":"A Roos","year":"2004","unstructured":"Roos A, Xu W, Castellano G, Nauta AJ, Garred P, Daha MR, van Kooten C (2004) Mini-review: A pivotal role for innate immunity in the clearance of apoptotic cells. Eur J Immunol 34:921\u2013929","journal-title":"Eur J Immunol"},{"key":"781_CR21","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1615\/CritRevImmunol.v25.i4.40","volume":"25","author":"J Tarr","year":"2005","unstructured":"Tarr J, Eggleton P (2005) Immune function of C1q and its modulators CD91 and CD93. Crit Rev Immunol 25:305\u2013330","journal-title":"Crit Rev Immunol"},{"key":"781_CR22","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1016\/j.molimm.2006.06.015","volume":"44","author":"M Oroszlan","year":"2007","unstructured":"Oroszlan M, Daha MR, Cervenak L, Prohaszka Z, Fust G, Roos A (2007) MBL and C1q compete for interaction with human endothelial cells. Mol Immunol 44:1150\u20131158","journal-title":"Mol Immunol"},{"key":"781_CR23","doi-asserted-by":"publisher","first-page":"2916","DOI":"10.4049\/jimmunol.178.5.2916","volume":"178","author":"H Ferry","year":"2007","unstructured":"Ferry H, Potter PK, Crockford TL, Nijnik A, Ehrenstein MR, Walport MJ, Botto M, Cornall RJ (2007) Increased positive selection of B1 cells and reduced B cell tolerance to intracellular antigens in c1q-deficient mice. J Immunol 178:2916\u20132922","journal-title":"J Immunol"},{"key":"781_CR24","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/S0022-2143(99)90179-8","volume":"133","author":"MP Soares","year":"1999","unstructured":"Soares MP, Bach FH (1999) C1q receptors and endothelial cell activation. J Lab Clin Med 133:520\u2013522","journal-title":"J Lab Clin Med"},{"key":"781_CR25","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/0272-6386(95)90566-9","volume":"25","author":"MM Schwartz","year":"1995","unstructured":"Schwartz MM, Korbet SM, Rydell J, Borok R, Genchi R (1995) Primary focal segmental glomerular sclerosis in adults: prognostic value of histologic variants. Am J Kidney Dis 25:845\u2013852","journal-title":"Am J Kidney Dis"},{"key":"781_CR26","doi-asserted-by":"publisher","first-page":"606","DOI":"10.2169\/internalmedicine.39.606","volume":"39","author":"H Shiiki","year":"2000","unstructured":"Shiiki H, Dohi K (2000) Primary focal segmental glomerulosclerosis: clinical course, predictors of renal outcome and treatment. Intern Med 39:606\u2013611","journal-title":"Intern Med"},{"key":"781_CR27","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1038\/sj.ki.5001903","volume":"70","author":"MB Stokes","year":"2006","unstructured":"Stokes MB, Valeri AM, Markowitz GS, D'Agati VD (2006) Cellular focal segmental glomerulosclerosis: Clinical and pathologic features. Kidney Int 70:1783\u20131792","journal-title":"Kidney Int"},{"key":"781_CR28","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1093\/ndt\/gfm523","volume":"23","author":"JK Deegens","year":"2008","unstructured":"Deegens JK, Steenbergen EJ, Borm GF, Wetzels JF (2008) Pathological variants of focal segmental glomerulosclerosis in an adult Dutch population epidemiology and outcome. Nephrol Dial Transplant 23:186\u2013192","journal-title":"Nephrol Dial Transplant"},{"key":"781_CR29","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1111\/j.1523-1755.2004.66038.x","volume":"66","author":"V Vielhauer","year":"2004","unstructured":"Vielhauer V, Berning E, Eis V, Kretzler M, Segerer S, Strutz F, Horuk R, Grone HJ, Schlondorff D, Anders HJ (2004) CCR1 blockade reduces interstitial inflammation and fibrosis in mice with glomerulosclerosis and nephrotic syndrome. Kidney Int 66:2264\u20132278","journal-title":"Kidney Int"},{"key":"781_CR30","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1097\/01.mnh.0000222691.53970.83","volume":"15","author":"C Zoja","year":"2006","unstructured":"Zoja C, Abbate M, Remuzzi G (2006) Progression of chronic kidney disease: insights from animal models. Curr Opin Nephrol Hypertens 15:250\u2013257","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"781_CR31","doi-asserted-by":"publisher","first-page":"457","DOI":"10.2353\/ajpath.2007.060554","volume":"170","author":"F Heller","year":"2007","unstructured":"Heller F, Lindenmeyer MT, Cohen CD, Brandt U, Draganovici D, Fischereder M, Kretzler M, Anders HJ, Sitter T, Mosberger I, Kerjaschki D, Regele H, Schlondorff D, Segerer S (2007) The contribution of B cells to renal interstitial inflammation. Am J Pathol 170:457\u2013468","journal-title":"Am J Pathol"},{"key":"781_CR32","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/j.1399-0012.2004.00292.x","volume":"19","author":"M Alausa","year":"2005","unstructured":"Alausa M, Almagro U, Siddiqi N, Zuiderweg R, Medipalli R, Hariharan S (2005) Refractory acute kidney transplant rejection with CD20 graft infiltrates and successful therapy with rituximab. Clin Transplant 19:137\u2013140","journal-title":"Clin Transplant"},{"key":"781_CR33","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1046\/j.1523-1755.1999.00299.x","volume":"55","author":"LC Racusen","year":"1999","unstructured":"Racusen LC, Solez K, Colvin RB, Bonsib SM, Castro MC, Cavallo T, Croker BP, Demetris AJ, Drachenberg CB, Fogo AB, Furness P, Gaber LW, Gibson IW, Glotz D, Goldberg JC, Grande J, Halloran PF, Hansen HE, Hartley B, Hayry PJ, Hill CM, Hoffman EO, Hunsicker LG, Lindblad AS, Marcussen N, Mihatsch MJ, Nadasdy T, Nickerson P, Olsen TS, Papadimitriou JC, Randhawa PS, Rayner DC, Roberts I, Rose S, Rush D, Salinas-Madrigal L, Salomon DR, Sund S, Taskinen E, Trpkov K, Yamaguchi Y (1999) The Banff 97 working classification of renal allograft pathology. Kidney Int 55:713\u2013723","journal-title":"Kidney Int"},{"key":"781_CR34","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1681\/ASN.2007010067","volume":"18","author":"T Ninomiya","year":"2007","unstructured":"Ninomiya T, Kubo M, Doi Y, Yonemoto K, Tanizaki Y, Tsuruya K, Sueishi K, Tsuneyoshi M, Iida M, Kiyohara Y (2007) Prehypertension increases the risk for renal arteriosclerosis in autopsies: the Hisayama Study. J Am Soc Nephrol 18:2135\u20132142","journal-title":"J Am Soc Nephrol"},{"key":"781_CR35","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1007\/s00467-006-0102-x","volume":"21","author":"K Dittrich","year":"2006","unstructured":"Dittrich K, Knerr I, Rascher W, Dotsch J (2006) Transient insulin-dependent diabetes mellitus in children with steroid-dependent idiopathic nephrotic syndrome during tacrolimus treatment. Pediatr Nephrol 21:958\u2013961","journal-title":"Pediatr Nephrol"},{"key":"781_CR36","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/S1262-3636(06)72809-9","volume":"32","author":"A Penfornis","year":"2006","unstructured":"Penfornis A, Kury-Paulin S (2006) Immunosuppressive drug-induced diabetes. Diabetes Metab 32:539\u2013546","journal-title":"Diabetes Metab"},{"key":"781_CR37","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.tem.2006.03.006","volume":"17","author":"PA Silveira","year":"2006","unstructured":"Silveira PA, Grey ST (2006) B cells in the spotlight: innocent bystanders or major players in the pathogenesis of type 1 diabetes. Trends Endocrinol Metab 17:128\u2013135","journal-title":"Trends Endocrinol Metab"},{"key":"781_CR38","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1210\/jc.2003-031360","volume":"89","author":"BM Brooks-Worrell","year":"2004","unstructured":"Brooks-Worrell BM, Greenbaum CJ, Palmer JP, Pihoker C (2004) Autoimmunity to islet proteins in children diagnosed with new-onset diabetes. J Clin Endocrinol Metab 89:2222\u20132227","journal-title":"J Clin Endocrinol Metab"},{"key":"781_CR39","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s11010-006-9251-2","volume":"294","author":"J Rinta-Valkama","year":"2007","unstructured":"Rinta-Valkama J, Palmen T, Lassila M, Holthofer H (2007) Podocyte-associated proteins FAT, alpha-actinin-4 and filtrin are expressed in Langerhans islets of the pancreas. Mol Cell Biochem 294:117\u2013125","journal-title":"Mol Cell Biochem"},{"key":"781_CR40","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1093\/ndt\/gfl486","volume":"22","author":"P Aaltonen","year":"2007","unstructured":"Aaltonen P, Rinta-Valkama J, Patari A, Tossavainen P, Palmen T, Kulmala P, Knip M, Holthofer H (2007) Circulating antibodies to nephrin in patients with type 1 diabetes. Nephrol Dial Transplant 22:146\u2013153","journal-title":"Nephrol Dial Transplant"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-008-0781-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-008-0781-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-008-0781-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-008-0781-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,16]],"date-time":"2021-01-16T17:12:10Z","timestamp":1610817130000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-008-0781-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":40,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["781"],"URL":"https:\/\/doi.org\/10.1007\/s00467-008-0781-6","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,8]]},"assertion":[{"value":"2 November 2007","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2007","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2008","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2008","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}